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Albumin is ﬁltered through the glomerulus with a sieving coeﬃcient of 0.00062, which results in approximately 3.3g of
albumin ﬁltered daily in human kidneys. The proximal convoluted tubule reabsorbs 71%, the loop of Henle and distal tubule
23%, and collecting duct 3% of the glomerular ﬁltered albumin, thus indicating that the kidney plays an important role
in protein metabolism. Dysfunction of albumin reabsorption in the proximal tubules, due to reduced megalin expression,
may explain the microalbuminuria in early-stage diabetes. Meanwhile, massive nonselective proteinuria is ascribed to various
disorders of the glomerular ﬁltration barrier, including podocyte detachment, glomerular basement membrane rupture, and slit
diaphragm dysfunction in focal segmental glomerulosclerosis, membranous nephropathy, and other glomerulonephritis. Selective
albuminuriaassociatedwithfootprocesseﬀacementandtightjunction-likeslitalterationisobservedinthepatientswithminimal-
change nephrotic syndrome, and the albumin uptake is enhanced in the podocyte cell body, possibly mediated by albumin
receptorsinthelow-dosepuromycinmodel.Theroleofenhancedpodocytealbumintransportneedstobeinvestigatedtoelucidate
the mechanism of the selective albuminuria in minimal-change disease.
1.Introduction
The kidneys are responsible for maintaining the homeostasis
of body ﬂuids by the regulation of water balance, electrolyte
balance, acid-base balance, and excretion of uremic toxins,
and also production of various hormones such as renin,
erythropoietin, and activation of vitamin D3.H o w e v e r ,
little attention has so far been paid to the role of protein
metabolism by the kidney. Primitive urine ﬁltered by the
glomerulus contains many proteins smaller than albumin,
and the renal proximal tubules actively reabsorb these
proteins, which are subsequently degraded to amino acids
in lysosomes and returned to the blood [1]. This paper
describes the mechanisms and pathways of glomerular
albumin ﬁltration and the amount of tubular reabsorption
of albumin along the nephron in normal and pathological
conditions based on our previous micropuncture studies.
The concept that glomerular albumin ﬁltration is restricted
by the size and charge barriers of the glomerular base-
ment membrane, and ﬁnally by the ﬁne pores of the slit
d i a p h r a g m ,i sw i d e l ya c c e p t e d .H o w e v e r ,S m i t h i e s[ 2] raised
an essential issue; why do the slit diaphragms not “clog” with
albumin if all ﬁltered albumin molecules pass through them?
Although glomerular albumin ﬁltration could be performed
by the diﬀusion of albumin back and forth across the GBM
[3],howalbuminmoleculescandiﬀuseoutacrosstheeﬀaced
podocyte foot processes entirely covering the basement
membrane in minimal-change nephrotic syndrome remains
unclear. This paper discusses the ultrastructural morpholog-
ical changes of the glomerular ﬁltration barrier in various
glomerular diseases and proposes a new mechanism of
glomerular albumin ﬁltration in minimal-change nephrotic
syndrome.
2. Albumin Filtration by the Glomerulus
under Normal Conditions
Albumin contains three spherical domains, with a molecular
weight of 69kDa and a net charge of −15. It is a ﬂexible,2 International Journal of Nephrology
Table 1: Comparison of the glomerular albumin-sieving coeﬃcient (SC) values.
Authors, year Method SC Species/animal model
Tojo and Endou [12], 1992 Fractional micropuncture 0.00062 rat
Bertolatus and Hunsicker
[62], 1985
131I-labeled BSA measuring urinary excretion and total
kidney uptake minus interstitial nonﬁltration uptake
0.0006 rat
0.021 hexadimethrine nephrotic rat
0.025 adriamycin nephrotic rat
131I-labeled neutral BSA 0.026 rat
Lund et al. [18], 2003
125I-native human serum albumin measuring both
kidney uptake and urinary excretion 0.00066 rat
125I-neutral human serum albumin 0.0065 rat
Norden et al. [13], 2001 urinary albumin excretion of congenital Fanconi
syndrome patients 0.00008 human
Tencer et al. [63], 1998 Blockade of proximal tubular reabsorption by L-lysine
0.00033 rat
0.0591 puromycin aminonucleoside
nephrotic rat
Ohlson et al. [64], 2000 Inhibition of tubular function by cooling (8◦C) 0.0019 rat
Christensen et al. [23],
2007
urinary albumin excretion of megalin-knockout mice 0.00016 megalin-knockout mice
Eppel et al. [14], 1999 tritium-labeled albumin 0.074 rat
Russo et al. [15], 2007 Alexa-labeled albumin, confocal microscopy 0.0341 rat
Tanner [16] Alexa-labeled rat serum albumin, two-photon
microscope with internal photodetectors 0.002 Munich-Wistar rat
ellipsoid-shaped molecule, 3.8nm in diameter and 15nm
longmolecule[1,4].Theslitporesizewasoriginallyreported
to be a rectangular pore approximately 40 by 140 ˚ Ai nc r o s s
section and 70 ˚ Ai nl e n g t h[ 5], and as a recent electron
tomography study revealed, the glomerular slit-pores are
35 ˚ A (3.5nm) in diameter with some variation in size [6].
These measurements were performed on samples processed
for electron microscopy, in which a slight reduction in size
is inevitable, so the true size of these pores are likely to
be larger than these values. Although the eﬀective Stock-
Einstein radius of albumin is 35 ˚ A( 7 0˚ A in diameter), some
albumin molecules are able to pass through the slit pores,
due to their ﬂexibility and ellipsoid shape. This is consistent
with the observation of FITC-labeled albumin on the slit
diaphragms between foot processes, indicating that a small
fraction of albumin could pass through the slit pores in
normal rats [7]. Early micropuncture studies demonstrated
albumin concentration values form 3 to 728μg/mL in
primitive urine in Bowman’s capsule in normal rats [8–11].
The large variation has been interpreted as contamination
with albumin in the serum from the peritubular capillar-
ies during the collection of tubular ﬂuid. Therefore, the
fractional micropuncture method was developed to avoid
serum albumin contamination. Renal tubules are initially
punctured with an outer pipette, and then four fractions
of tubular ﬂuid are collected with an inner pipette. The
albumin concentration is measured in the fourth fraction of
tubular ﬂuid, which is virtually free from contamination by
serum albumin, yielding a value of 22.9μg/mL in Bowman’s
capsule, and an albumin-sieving coeﬃcient of 0.00062 [12].
Isotope-labeled albumin clearance studies, which mea-
sured both urinary excretion and tubular uptake, divided by
the plasma isotope level, showed consistent values with our
fractional micropuncture data (Table 1). Albumin clearance
studies after blocking proximal tubular reabsorption with
L-lysine, treatment with low temperatures, or studies of
congenital abnormalities of tubular reabsorption showed
slightly smaller values in comparison to the micropuncture
data.
ThefractionalexcretionofalbumininFanconisyndrome
patients is 0.00008, and this may be approximately equiv-
alent to the glomerular-sieving coeﬃcient in the normal
kidney [13]. However, nephron segments downstream of
the proximal convoluted tubules can reabsorb about 26%
of glomerular ﬁltrated albumin even if proximal tubular
albumin reabsorption is impaired in Fanconi syndrome,
(Figure 1). Therefore, the glomerular albumin-sieving coef-
ﬁcient may actually be greater than 0.00011 in humans.
Larger amounts of glomerular albumin ﬁltration have
been reported. One study using tritium-labeled albumin
demonstrated a sieving coeﬃcient of 0.074 [14], and another
study using Alexa-labeled albumin observed by confocal
microscopy resulted in a sieving coeﬃcient of 0.0341 [15],
which is 50 to 100 times higher values than previous studies.
However, there were several technical limitations including
the sensitivity of the measurement methods, the interference
by out-of-focus ﬂuorescence, and the incomplete removal
of unbound labeling molecules, which can freely pass the
glomerular ﬁltration barrier. These values also seem unreal-
istically high from the viewpoint of albumin metabolism.International Journal of Nephrology 3
albumin concentration 22.9 µg/mL
Normal rat
37%
34%
3%
23%
14.4 ±1.9µg/mL
63%
100%
1.3 ±0.5µg/mL
6%
0.7 ±0.2µg/mL
3%
6.7 ±2.9µg/mL
29%
Bowman’s capsule:
Sieving coeﬃcient: 0.00062
Figure 1: Albumin concentration along the nephron calculated
from the data from a rat fractional micropuncture study [12].
The problem of out-of-focus ﬂuorescence contaminating
the signal from Bowman’s capsule was solved by performing
two-photon microscopy studies utilizing internal photode-
tectors, and the glomerular-sieving coeﬃcient was calculated
as0.002withAlexaﬂuorlabeled-ratserumalbumin[16]and
0.001withRhodaminelabeled70-kDdextran[17],whichare
closer to the values estimated from micropunctures.
The glomerular-sieving coeﬃcient is not a static constant
parameter. The value changes in response to oscillational
changes in GFR, temperature or laparotomy during experi-
ments [17–20], and it may vary in the range from 0.0001 to
0.0006 under normal conditions.
3. The Important Role of the Kidney in
the ProteinMetabolism
Albumin concentration along the rat nephron was mea-
sured in fractional micropuncture studies (Figure 1)[ 12].
Renal tubules reabsorb about 3g of albumin per day
in humans (Table 2). The albumin reabsorption capacity
measured in the isolated rabbit proximal tubule was 99.9 ×
10−3 ng/min/mm [21]. The length of the proximal tubule is
6.5mm [22], so human kidneys can be estimated to reabsorb
1.9g (99.9 × 10−3 ng/min/mm × 24h × 60min × 6.5mm
× 2 × 106 nephron) of albumin per day. The nephron
segments downstream of the proximal convoluted tubules
further reabsorbs about 26% of ﬁltered albumin, thus the
total amount of albumin reabsorption in the kidney comes
to 2.6g a day, which is consistent with the micropuncture
data. Albumin molecules are taken up into lysosomes in the
proximal tubule within 6 to15 minutes and then degraded to
amino acids after 30 to 120 minutes in the proximal tubule
[1, 21]. Therefore, the kidney should be regarded as an organ
that plays an important role in the protein metabolism.
The high sieving coeﬃcient values reported by Russo
et al. [15], which suggest that about 200g of albumin per
day are ﬁltered in the glomerulus and reabsorbed in the
proximal tubule, seem highly unlikely. In fact, abundant
amounts of albumin cannot be detected in the normal
kidney by immunostaining. In addition, the proximal tubule
is unlikely to be able to transport such huge amounts of
intact albumin under physiological conditions [21, 23, 24].
It is unreasonable that albumin ﬁltration and metabolism in
the kidney is larger than the daily production by the liver
(∼20g), or than the total plasma albumin (∼125g).
On the other hand, low molecular weight proteins are
almostallfreelyﬁlteredattheglomeruluswithasievingcoef-
ﬁcient of 0.987 [12] and about 9.6g are reabsorbed per day
(Table 2). The tubular dysfunction of protein metabolism
in chronic renal failure cannot be compensated for by
hemodialysis, so low molecularweight protein deposits, such
as β2-microglobulin, in various organs, cause amyloidosis
in hemodialysis patients. The physiological role of protein
metabolism in the kidney must be accounted for.
4. Mechanismof Microalbuminuriain
DiabeticNephropathy
Microalbuminuria is an early marker of diabetic nephropa-
thy and is believed to occur due to increased glomerular
permeability and glomerular hyperﬁltration [25, 26]. How-
ever, a fractional micropuncture study demonstrated the
proximal tubular albumin reabsorption to decrease without
an increase in the glomerular albumin ﬁltration in the
early stages of streptozotocin-induced diabetic nephropathy
(Figure 2)[ 27]. This tubular dysfunction may be one of the
mechanismsofmicroalbuminuriaintheearly-stagediabetes.
This is supported by the ﬁnding that megalin, the receptor
foralbuminendocytosisintheproximaltubules,isdecreased
in diabetic rats [27], and by the measurement of albumin
clearance after the blockade of proximal reabsorption with
lysine, utilizing isotope labeled-bovine serum albumin [28].
There is a possibility that the true amount of albuminuria
may be larger than that detected in the urine by measuring
the intact albumin, because albumin degrades to fragmented
albumin by brush border enzymes in the proximal tubules,
[29].
Renin-angiotensin system (RAS) inhibitors are reported
to restore megalin expression, ameliorate the tubular
dysfunction of albumin reabsorption, and reduce albu-
m i n u r i ai nd i a b e t i cr a t s[ 30]. Albumin is reabsorbed
by receptor-mediated endocytosis into endosomes, where
ligand-receptor dissociation must occur to recycle the4 International Journal of Nephrology
Table 2: Glomerular ﬁltration and reabsorption of albumin and low-molecular weight proteins (LMWP) in humans estimated from rat
micropuncture data [12].
Albumin LMWP
Bowman’s capsule concentration 22.9μg/mL 72.1μg/mL
Plasma concentration 37.0mg/mL 73.0μg/mL
Sieving coeﬃcient 0.00062 0.987
Estimated glomerular ﬁltration amount in
humans
22.9μg/mL × 100mL/min × 24h ×
60min = 3.3g/day
72.1μg/mL × 100mL/min × 24h ×
60min = 10.4g/day
Estimated tubular reabsorption in humans 3.2g/day 9.6g/day
Tubular albumin delivery 
along the nephron
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Figure 2: Tubular albumin reabsorption in diabetic nephropathy calculated from the data from a rat fractional micropuncture study.
Albumin reabsorption in the proximal convoluted tubules (PCT) is signiﬁcantly reduced in diabetes mellitus (DM) rats, resulting in higher
albumin delivery in the distal convoluted tubules (DCT) and urine in DM rats than in normal controls.
albumin-binding receptors back to the plasma membrane.
Vesicular acidiﬁcation by H+-ATPase, CLC-5, NHE-3 is
functionally important for the pH-dependent dissociation
between albumin and megalin, and eﬀective albumin reab-
sorption[1,31].RenaltissueangiotensinIIlevelsareelevated
in diabetes [32]. Angiotensin II blocks H+-ATPase [33], thus
acidiﬁcation of endosomes may be reduced by inhibition
of H+-ATPase by renal angiotensin II, thus leading to
decreased albumin reabsorption. Therefore, RAS inhibitors
not only prevent intraglomerular hypertension and disrupt
of glomerular permselectivity [34], but also restore albumin
metabolism in the proximal tubules.
5. Questions Pertainingto Glomerular
AlbuminFiltrationthrough Slit Poresin
the Nephrotic Syndrome
The glomerular ﬁltration barrier is made up of three layers;
(1) the fenestrated endothelium covered by a negatively
charged glycocalyx, (2) the glomerular basement membrane,
where a size barrier is containing laminin and type IV
collagen and a charge barrier generated by heparan sulfate
is presumed to function as a coarse barrier, (3) and ﬁnally
the slit diaphragm between foot processes, which is regarded
as a ﬁne ﬁlter [35]. Yamada identiﬁed the slit diaphragmInternational Journal of Nephrology 5
(a) (b)
(c) (d)
Figure 3: Electron microscopy of human renal biopsy samples. (a) Glomerular basement membrane rupture (arrowhead) in IgA
nephropathy. (b) Podocyte loss and a denuded glomerular basement membrane in focal segmental glomerulosclerosis. Proteins were
observed as nonuniform electron dense substances in the capillary lumen and also in the urinary space adjacent to the denuded glomerular
basement membrane (arrow heads), suggesting large amounts of protein including albumin ﬁltered through the denuded glomerular
basement membrane, leading to proteinuria. (c) Podocyte detachment and apoptosis in membranous nephropathy with subepithelial
electron dense deposits. (d) Diﬀuse foot process eﬀacement with reduction of the slit membranes in minimal-change nephrotic syndrome.
Bars indicate 500nm.
by electron microscopy in 1955 [36] and Rodewald and
Karnovsky identiﬁed the zipper-like structure of the slit
membrane [5], indicating that albumin is ﬁltered through
the slit pores, similar to water, ions, and low molecu-
lar proteins. Experiments using various tracers raised the
controversy over whether the GBM or the slit diaphragm
is the most crucial restrictive ﬁltration barrier; ferritin
accumulates in the GBM, but not under the slit diaphragm
[37], whereas horseradish peroxidase (HRP) is observed
on the slit diaphragm as well as on the GBM [38, 39].
The identiﬁcation of nephrin at the slit diaphragm and its
mutationintheFinnish-typecongenitalnephroticsyndrome
provided crucial evidence that the slit membrane is the main
component of the glomerular ﬁltration barrier [40, 41].
However, the importance of the GBM cannot be ignored,
for laminin β2 (LAMB2) knockout mice show a severe
disorganization of the GBM structure, and accompanying
proteinuria [42]. In addition, the importance of the charge
barrier of GBM needs to be further investigated. Heparan
sulfate synthase deﬁcient mice do not show proteinuria even
though they show reduction of the negative charge of the
GBM and foot process eﬀacement [43].
Therefore, both the slit diaphragm and the GBM are
important for a functioning glomerular ﬁltration barrier.
However, several critical questions need to be answered
before accepting the concept of albumin ﬁltration through
slit pores, (1) albumin does not accumulate under the slit
diaphragm in tracer studies, (2) the sieving coeﬃcient of
albumin is much lower than Dextran or Ficoll of similar
size, which cannot be fully explained from diﬀerences in
ﬂexibility of the molecular shape and charge between these
molecules [4, 44], (3) the glomerular sieving coeﬃcient to
albumin should increase at high glomerular ﬁltration rates,
if the slit pores are the main barrier for albumin restriction;
however, the opposite phenomenon has also been reported
[18], (4) the number of slit diaphragms decreases with
a tight junction like structural change in minimal-change
nephrotic syndrome, and (5) reduction of nephrin may
cause enlargement of the slit pores, that can explain massive
proteinuriabutnotselectivealbuminuriainminimal-change6 International Journal of Nephrology
GBM
Impaired slit diaphragms
Podocyte detachment
Receptor-mediated transport
Pore size enlarged
Pore size unchanged or diminished
GBM
GBM
→ nonselective proteinuria
→ selective proteinuria
FcRn
Heavy molecular weight proteins
Albumin
Figure 4: Possible mechanisms of albuminuria in minimal-change nephrotic syndrome. Albumin is ﬁltered through the endothelial
fenestrae, the basement membrane, and ﬁnally through the impaired slit diaphragm. Albumin is also ﬁltered through the glomerular
capillary wall where podocytes are lost by podocyte detachment or apoptosis causing enlarged slit pores and nonselective proteinuria. A
mechanism of receptor-mediated albumin transport via FcRn through podocytes may explain the selective albuminuria in minimal-change
disease.
nephrotic syndrome. It is noteworthy that both HRP and
ferritin tracers are identiﬁed in the podocyte cytoplasm
in some tracer studies [37, 39]thus suggesting that some
transport mechanism may also exist for albumin.
6. Electron Microscopic Observation of
VariousMechanismsof Proteinuriain
Glomerular Diseases
Careful observation of human renal biopsies in electron
microscopy images makes it possible to identify lesions
responsible for proteinuria in various glomerular diseases
(Figure 3). Glomerulonephritis including IgA nephropa-
thy, ANCA-related nephritis, acute glomerulonephritis, and
lupus nephritis show damage of the GBM by inﬂammatory
cells forming ruptures or holes causing nonselective protein-
uria with accompanying hematuria (Figure 3(a)). Podocyte
detachment and podocyte apoptosis are observed in focal
segmental glomerulosclerosis and membranous nephropa-
thy, and proteins leak from the site of denuded GBM,
causingnonselectiveproteinuria(Figures3(b)and3(c)).The
denuded GBM is prone to adhere to the Bowman’s capsule,
resulting in segmental sclerosis. Podocyte detachment or
apoptosis could occur by various mechanisms including
hemodynamic stretching, immunological mechanisms such
as immune complex deposition, integrin-dependent signal-
ing, and oxidative stress derived from NADPH oxidase fol-
lowing stimulation by angiotensin II and cytokines [45–49].
These ultrastructural morphological changes of the GBM
may represent the shunt pathway assumed in mathematical
models of glomerular permselectivity [3, 50]. While these
ﬁndings are often observed in focal segmental glomeru-
losclerosis and the “high dose” puromycin aminonucleoside
nephrotic syndrome model [50], such shunts are rarely
observed in both human minimal-change nephrotic syn-
drome and the low-dose puromycin model.
7.PossibleMechanismsofSelective
AlbuminuriainMinimal-Change
Nephrotic Syndrome
Possible mechanisms of proteinuria in minimal-change
nephrotic syndrome are schematically shown in Figure 4.
The common assumption is that proteins leak from the slit
pores due to reduced nephrin expression, while podocyte
detachment is rarely observed [51, 52]. Podocytes with
eﬀaced foot processes widely cover the glomerular capillary
wall in minimal change nephrotic syndrome (Figure 3(d)),
and podocyte slit pore density is decreased by 80% at
most, and half of the slits display a tight-junction-like
structure [51]. These structural changes in the podocytesInternational Journal of Nephrology 7
raise the question of which route albumin actually passes
through. Even if massive amounts of albumin are ﬁltered
through the altered slit membrane, it is diﬃcult to explain
the selective proteinuria by decrease in nephrin, which
should lead to enlarged slit pores. In addition, there is
discrepancy in time between the peaks of proteinuria and
the expression of nephrin in the nephrotic model induced by
an antibody against nephrin [53, 54] and in the puromycin
aminonucleoside model [55]. It is possible that reduced
nephrin expression is not a cause of nephrotic syndromes,
but merely a reﬂection of the decrease in slit pore number.
The results of labeled albumin tracer studies suggest that
albumin may be transported through the podocyte cell
body by endocytosis and exocytosis [7]. This hypothesis
was conﬁrmed using Evans blue (EB, molecular weight
961Da) labeled albumin, which strongly binds to albumin
without altering albumin’s molecular weight, and shows
red ﬂuorescence, in the puromycin nephrotic model in
GFP transgenic rats [56]. Podocytes emitting green GFP
ﬂuorescence turn yellow after the uptake of EB-labeled
albumin. There is an initial delay of approximately 5
minutes before appearance of EB-albumin in the tubular
lumen, which may be due to the time needed for the
transcellular transport of albumin [56]. There are several
receptors for albumin including megalin and cubilin in the
proximal tubule [57], gp60 in the endothelium [58], and
FcRn in podocytes [59, 60]. Interestingly, blocking the FcRn
receptor with an antibody for FcRn reduces proteinuria, thus
suggesting that the transport of albumin in the podocyte is
at least partially mediated by FcRn [56]. The capacity for
albuminendocytosisislargeenoughtoexplaindailyalbumin
ﬁltration through the podocytes (Vmax 97.4μg/mg cell
protein/h) [61]. This value indicates that the estimated total
endocyticcapacityinhumankidneysis3.6g/day[97.4μg/mg
cell protein/h × 0.21mg cell protein/mg cell × cell volume
(4/3)π × (10μm)3× 878 podocytes per glomerulus × 2 ×
106 glomeruli per kidney × 24h].
These ﬁndings shed new light on the possibility of
ﬁltration pathways of albumin through the podocyte cell
body via receptor-mediated transcytosis. This mechanism
of albumin ﬁltration may answer the essential question
raised by Smithies [2] of why the slit diaphragms do not
“clog” with albumin in nephrotic syndrome. Further studies
are necessary to elucidate how albumin is transported and
excreted through the podocyte cell body.
8. Conclusion
In conclusion, the glomerular-sieving coeﬃcient of albumin
is 0.00062, and the kidney plays an important role in protein
metabolism.Tubulardysfunctionofalbuminendocytosisvia
megalin can explain the microalbuminuria in the early-stage
diabetic nephropathy. The identiﬁcation of nephrin indi-
cated that the slit diaphragm with slit pores may be a restric-
tion ﬁlter for albumin molecules. Podocyte detachment and
apoptosis or GBM rupture may explain the nonselective
proteinuria with or without hematuria. Meanwhile, selective
albuminuria in minimal-change nephrotic syndrome may be
explained by the receptor-mediated transcytosis of albumin
bypodocytes,andthiscouldbeanewtargetforthetreatment
of the nephrotic syndrome.
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